Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.
Nodal Therapeutics has raised $500K in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Nodal Therapeutics's investors include TEDCO.
Nodal Therapeutics is headquartered in Silver Spring, United States.
Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.
Nodal Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nodal Therapeutics — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/nodal-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Nodal Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nodal-therapeutics
{{cite web |title=Nodal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nodal-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated